Capula Management’s Terns Pharmaceuticals TERN Stock Holding History

Capula Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-120,976	Closed	-$6.38M	–	1111
2026 Q1	$6.38M	Buy	+120,976	New	+$4.97M	0.05%	112

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Capula Management's TERN Position: Q2 2026 in Review

Capula Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 120,976 shares — an estimated $6.38M sold.

Capula Management first reported a position in TERN in Q1 2026 and held it in 1 quarter. The position peaked at $6.38M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Capula Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Capula Management sold 120,976 Terns Pharmaceuticals shares in Q2 2026, an estimated $6.38M.
Capula Management first reported a position in Terns Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Capula Management's Terns Pharmaceuticals position peaked at $6.38M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.